chr15-39976730-G-GCACT
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001013703.4(EIF2AK4):c.2136_2139dupCACT(p.Ser714HisfsTer21) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000025 in 1,602,116 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
EIF2AK4
NM_001013703.4 frameshift
NM_001013703.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.10
Publications
2 publications found
Genes affected
EIF2AK4 (HGNC:19687): (eukaryotic translation initiation factor 2 alpha kinase 4) This gene encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the downregulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2. [provided by RefSeq, Mar 2014]
EIF2AK4 Gene-Disease associations (from GenCC):
- pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary venoocclusive disease 2Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulmonary venoocclusive diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-39976730-G-GCACT is Pathogenic according to our data. Variant chr15-39976730-G-GCACT is described in ClinVar as Pathogenic. ClinVar VariationId is 426054.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EIF2AK4 | ENST00000263791.10 | c.2136_2139dupCACT | p.Ser714HisfsTer21 | frameshift_variant | Exon 12 of 39 | 2 | NM_001013703.4 | ENSP00000263791.5 | ||
| EIF2AK4 | ENST00000560855.5 | c.1551_1554dupCACT | p.Ser519fs | frameshift_variant | Exon 8 of 34 | 5 | ENSP00000453575.1 | |||
| EIF2AK4 | ENST00000624709.1 | n.-249_-248insCACT | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000133 AC: 3AN: 226152 AF XY: 0.0000160 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
226152
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1449912Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 721296 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
1449912
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
721296
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32450
American (AMR)
AF:
AC:
0
AN:
43930
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25888
East Asian (EAS)
AF:
AC:
0
AN:
39126
South Asian (SAS)
AF:
AC:
0
AN:
84946
European-Finnish (FIN)
AF:
AC:
0
AN:
48486
Middle Eastern (MID)
AF:
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1109270
Other (OTH)
AF:
AC:
0
AN:
60056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74354
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41466
American (AMR)
AF:
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68026
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Familial pulmonary capillary hemangiomatosis Pathogenic:1
-
Rare Disease Genomics Group, St George's University of London
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.